These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7128460)

  • 1. Pharmaceutical services at a U.S. Bureau of Prisons facility.
    Hadd NA
    Drug Intell Clin Pharm; 1982 Sep; 16(9):680-1. PubMed ID: 7128460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Federal Bureau of Prisons HIV consultant pharmacist monitoring and advisory program.
    Bingham JT
    J Am Pharm Assoc (2003); 2012; 52(6):798-801. PubMed ID: 23229967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Federal Bureau of Prisons clinical pharmacy program improves patient A1C.
    Bingham JT; Mallette JJ
    J Am Pharm Assoc (2003); 2016; 56(2):173-7. PubMed ID: 27000168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial stewardship in the Federal Bureau of Prisons: Approaches from the national and local levels.
    Long MJ; LaPlant BN; McCormick JC
    J Am Pharm Assoc (2003); 2017; 57(2):241-247. PubMed ID: 28089415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacist Services on Admission to a Large Correctional Center.
    Bhat A; Gunther M; Bungard TJ; MacLennan S; Taube K; Macek P
    J Correct Health Care; 2020 Apr; 26(2):105-112. PubMed ID: 32390542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Case and Mortality Rates in the Federal Bureau of Prisons.
    Toblin RL; Hagan LM
    Am J Prev Med; 2021 Jul; 61(1):120-123. PubMed ID: 33781619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of challenging HIV case consultations provided via teleconference by the Clinician Consultation Center to the Federal Bureau of Prisons.
    Dong BJ; Williams MR; Bingham JT; Tokumoto J; Allen JD
    J Am Pharm Assoc (2003); 2017; 57(4):516-519. PubMed ID: 28610939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Correctional and Community Health Care: An Innovative Approach for Clinical Learning in a Baccalaureate Nursing Program.
    Bouchaud MT; Swan BA
    Nurs Forum; 2017 Jan; 52(1):38-49. PubMed ID: 27102579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of pharmacy services in Portuguese prisons: a national survey.
    Alexandra Monteiro Guerra L; Façanha da Cruz Fresco P
    Int J Prison Health; 2013; 9(4):187-95. PubMed ID: 25763454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical services in the United States Public Health Service.
    Paavola FG; Dermanoski KR; Pittman RE
    Am J Health Syst Pharm; 1997 Apr; 54(7):766-72. PubMed ID: 9099342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASHP guidelines on pharmaceutical services in correctional facilities. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1995 Aug; 52(16):1810-3. PubMed ID: 8528841
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of quality measures used by state and federal prisons.
    Damberg CL; Shaw R; Teleki SS; Hiatt L; Asch SM
    J Correct Health Care; 2011 Apr; 17(2):122-37. PubMed ID: 21525116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing role of the pharmacist in a long term care institution.
    Kay BG; Adelman DN; Brodsky H
    Long Term Care Health Serv Adm Q; 1977; 1(1):18-26. PubMed ID: 10308916
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and role of pharmacist in correctional facilities.
    Ta QTH; Nadeem MF; Matti N; Parveen S; Jawad M
    Res Social Adm Pharm; 2021 Jan; 17(1):2042-2043. PubMed ID: 32800459
    [No Abstract]   [Full Text] [Related]  

  • 15. "People don't understand what goes on in here": A consensual qualitative research analysis of inmate-caregiver perspectives on prison-based end-of-life care.
    Depner RM; Grant PC; Byrwa DJ; Breier JM; Lodi-Smith J; Luczkiewicz DL; Kerr CW
    Palliat Med; 2018 May; 32(5):969-979. PubMed ID: 29432706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of PAs in federal correctional institutions.
    Brutsche RL
    Physician Assist; 1986 Sep; 10(9):60-6. PubMed ID: 10314636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correctional facilities guidelines.
    Cason D; Keith MR
    Am J Health Syst Pharm; 1996 Feb; 53(3):320; author reply 320, 325. PubMed ID: 8808034
    [No Abstract]   [Full Text] [Related]  

  • 18. Compliance with federal regulations for pharmaceutical services in skilled nursing facilities.
    Brown CH; DeSimone EM
    Am J Hosp Pharm; 1981 Jul; 38(7):1014-7. PubMed ID: 7258199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying barriers to the administration of HIV medications to county correctional facility inmates.
    Miller SK; Rundio A
    Clin Excell Nurse Pract; 1999 Sep; 3(5):286-90. PubMed ID: 10763627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogeneity in prison risk classification.
    Shermer LO; Bierie DM; Stock A
    Int J Offender Ther Comp Criminol; 2013 Oct; 57(10):1248-74. PubMed ID: 22820050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.